BMC Medicine
Volume 16, Issue 1, 2018

Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants (Review) (Open Access)

Zumla A. , Abubakar I.*
  • a Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, United Kingdom, NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, United Kingdom
  • b UCL Institute for Global Health, University College London, London, United Kingdom

Abstract

By the end of 2017, an estimated 68.5 million people were displaced from their homes worldwide, of whom 25.4 million were refugees. The transmission and globalization of multi-drug resistant tuberculosis during refugee migration is a now priority issue in the public health agenda. Political and scientific commitment at the highest national and international levels will be critical to intensifying action in promoting improved health services for migrants and refugees. © 2018 The Author(s).

Author Keywords

Refugees tuberculosis Migrants Multi-drug resistant

Index Keywords

patient care refugee health promotion public health service Population Dynamics human Refugees health service multidrug resistant tuberculosis Tuberculosis, Multidrug-Resistant nonhuman screening disease course Humans migrant Review health services prevalence disease transmission disease control prophylaxis private sector migration isoniazid health care access global health Transients and Migrants disease burden rifampicin Health Services Accessibility public health health care delivery
Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057553194&doi=10.1186%2fs12916-018-1218-0&partnerID=40&md5=5b2202311baabf717875c66f3ef655d0
DOI: 10.1186/s12916-018-1218-0
ISSN: 17417015
Cited by: 1
Original Language: English